Dechra Announces FDA Approval of CosACTHen® (cosyntropin injection), the First and Only Cosyntropin Approved Specifically for Canine Patients

Dechra is proud to announce the U.S. Food and Drug Administration's (FDA) approval of CosACTHen® (cosyntropin injection), the ...
dvm360

FDA approves cosyntropin injection for use in canines

Officials with the FDA have approved the first cosyntropin indicated for canine diagnostic use. The approved cosyntropin ...
Nature

522 Low and Stardard Doses of Synthetic Acth in the Assessment of Adrenal Function of Children with Septic Shock

Background and method: ACTH stimulation test is used for the diagnosis of adrenal insufficiency in sepsis, but the optimal dosage of ACTH is still debatable. We, therefore, compared the efficacy of ...